新開普(300248.SZ):擬以9600萬元參設有限合夥企業
格隆匯2月21日丨新開普(300248.SZ)公佈,2022年2月18日,公司與上海五信投資管理有限公司(“上海五信”)、揚州冰靜投資合夥企業(有限合夥)(“揚州冰靜”)、吳雪明簽署了《揚州五信開普股權投資合夥企業(有限合夥)合夥協議》,約定共同投資設立揚州五信開普股權投資合夥企業(有限合夥)(暫定名,最終以市場監督管理機關登記為準),合夥企業出資額為人民幣1億元,公司以自有資金認繳出資額為9600萬元,佔註冊資本的96%。
合夥企業作為公司投資平台,有利於公司藉助專業機構的資源,提高對投資標的相關運作的專業性,為公司進一步鞏固行業地位、有效地產業整合提供支持,促進公司整體戰略目標的實現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.